1. Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials. (20th November 2013) Authors: Tanaka, Toshiaki; Kitamura, Hiroshi; Inoue, Ryuta; Nishida, Sachiyo; Takahashi-Takaya, Akari; Kawami, Sachiyo; Torigoe, Toshihiko; Hirohashi, Yoshihiko; Tsukamoto, Taiji; Sato, Noriyuki; Masumori, Naoya Other Names: Reche Pedro A. Academic Editor. Journal: Clinical & developmental immunology Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗